Ramsay Santé FY26 net loss narrows to €48.3 million; revenue rises to €5.38 billion
Bitget2026/10/06 15:35Ramsay Santé reported June 30, 2026 revenue of EUR 5.38 billion, up 3% year-on-year. Operating profit climbed 8% to EUR 186.3 million, while net result attributable to owners narrowed to a EUR 48.3 million loss. Net cash flow from operating activities fell to EUR 524.7 million, while net financial debt eased to EUR 3.58 billion. Management said revenue rose on “strong activity” and “continued operational discipline,” and it will not propose a dividend. Ramsay Santé said it closed a EUR 1.75 billion senior debt refinancing in July 2026, extending senior maturities to 2033. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Générale de Santé SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610061135OMX_____CNEWS_EN_GNW1001276590_en) on October 06, 2026, and is solely responsible for the information contained therein.
- Ramsay Santé reported June 30, 2026 revenue of EUR 5.38 billion, up 3% year-on-year.
- Operating profit climbed 8% to EUR 186.3 million, while net result attributable to owners narrowed to a EUR 48.3 million loss.
- Net cash flow from operating activities fell to EUR 524.7 million, while net financial debt eased to EUR 3.58 billion.
- Management said revenue rose on “strong activity” and “continued operational discipline,” and it will not propose a dividend.
- Ramsay Santé said it closed a EUR 1.75 billion senior debt refinancing in July 2026, extending senior maturities to 2033.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japan's 20-year government bond auction sees weak demand as bid-to-cover ratio drops sharply to 3.64, marking the lowest demand of the year
Japan's 20-year government bond auction saw weak demand, with the bid-to-cover ratio falling to 3.64 and the tail widening to its largest in a year. The market is concerned about fiscal budget issues and rising yields.

Google-backed AI pharmaceutical company raises $5 billion in funding, doubling the previous round
The current funding round for Isomorphic Labs is co-led by top VCs including Sequoia Capital and Andreessen Horowitz. This round comes only six months after the previous $2.1 billion Series B, with the scale more than doubling. By 2026, total financing in the AI pharmaceutical sector has reached a record high of $23.2 billion, with Anthropic and OpenAI also entering the field.
Japanese stocks closed up by 0.28%

Report: Apple Plans to Establish Multi-Year DRAM Agreement with Samsung, Deliveries to Begin in First Half of 2027
Apple and Samsung are in negotiations for a long-term DRAM chip supply agreement lasting four to five years, with deliveries expected to start in the first half of 2027. The agreement is expected to include a minimum supply commitment and set pricing linked to the market. Currently, Apple is one of the few major tech companies that have yet to sign a long-term DRAM supply deal with Samsung.
